window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Opinion & Events

  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events

    BioGrad leads £6 million PCR machine donation to strengthen UK science education

    BioGrad has led the donation of more than £6 million [...]

    May 5, 2026
  • Opinion & Events,Therapeutic Areas

    UAE obesity conference highlights global advances shaping the future of obesity care

    The 7th UAE Obesity Conference brought together international experts in [...]

    May 5, 2026
  • Manufacturing & Supply Chain,Opinion & Events,Pharmaceuticals and therapeutics

    CPHI & PMEC India 2025 returns to Delhi as South Asia’s largest pharma event

    CPHI & PMEC India will return to the India Expo [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Terumo BCT and Santersus partner to advance therapeutic apheresis for sepsis treatment

    Terumo Blood and Cell Technologies (Terumo BCT) and Santersus AG [...]

    May 5, 2026
  • Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    Every day is a balancing act: One Mum’s journey raising a daughter with Type 1 diabetes

    This is a disease awareness paid article sponsored by Sanofi. [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction

    Clairity, an AI-driven precision health company, has raised $43 million [...]

    May 5, 2026
  • Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    Almirall ImmunoSkin brings experts together to advance treatment of inflammatory skin diseases

    Almirall has hosted the fourth edition of ImmunoSkin, its annual [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events

    Abselion launches His-tag protein quantification kit and sensors for Amperia at PEGS Europe 2025

    Abselion has expanded its Amperia assay portfolio with the launch [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    Medicinova wins contract research and development innovation award at biotech breakthrough awards 2025

    MediciNova has been recognised with the Contract Research and Development [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain,Opinion & Events,Pharmaceuticals and therapeutics

    Personal connections at CPhI Frankfurt 2025: How trust drives long-term pharma relationships

    A roundtable at CPhI Frankfurt 2025 with industry leaders from [...]

    May 5, 2026
Previous345Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FairJourney Bio opens cryo-EM facility in San Diego for antibody discovery
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain
  • Kinesin-2 motor variants shown to control cargo transport in neurons
    Categories: Drug Discovery & Development, Therapeutic Areas
  • Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome
    Categories: Central Nervous System, Clinical & Regulatory, Drug Delivery & Formulation, Drug Discovery & Development, Opinion & Events, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top